FMP
GlucoTrack, Inc.
GCTK
NASDAQ
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
0.352 USD
-0.0055 (-1.56%)
GCTK Financial Statements
Year
2023
2022
2021
2020
Total Revenue
0
0
0
0
Cost of Revenue
13k
23k
42k
47k
Gross Profit
-13k
-23k
-42k
-47k
Operating Expenses
7.1M
4.43M
3.98M
3.13M
Research and Development
4.69M
1.97M
1.81M
1.53M
Selling, General & Administrative Expenses
2.4M
2.45M
2.12M
1.56M
Selling & Marketing Expenses
122k
0
139k
415k
General & Administrative Expenses
2.28M
2.45M
1.98M
1.14M
Other Expenses
0
11k
51k
43k
Operating Income
-7.1M
-4.43M
-4.04M
3.13M
Total Other Income/Expenses Net
7k
-3k
-27k
436k
Income Before Tax
-7.1M
-4.43M
-4.07M
-2.7M
Income Tax
0
3k
33k
-98k
Net Income
-7.1M
-4.44M
-4.1M
-2.6M
Basic EPS
-1.92
-0.29
-0.27
-0.17
EPS Diluted
-1.92
-0.29
-0.27
-0.17
Basic Average Shares
4.15M
15.47M
15.45M
15.08M
Diluted Average Shares
4.15M
15.47M
15.45M
15.08M
EBITDA
-7.09M
-4.41M
-4M
-3.08M
Retained Earning Schedule
Year
2023
2022
2021
2020
Retained Earnings (Previous Year)
-101.9M
-97.47M
-93.4M
-90.7M
Net Income
-7.1M
-4.44M
-4.1M
-2.6M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-109.85M
-101.9M
-97.47M
-93.4M
Other Distributions
-7.95M
-4.43M
-4.07M
-2.7M
PPE Schedule
Year
2023
2022
2021
2020
Gross PPE
27k
40k
109k
315k
Annual Depreciation
13k
23k
42k
47k
Capital Expenditure
0
-1k
-5k
-53k
Net PPE
14k
18k
72k
321k
Intangible and Goodwill Schedule
Year
2023
2022
2021
2020
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
